메뉴 건너뛰기
Tropical Doctor
Volumn 38, Issue 2, 2008, Pages 91-93
Risk factors for drug resistant tuberculosis in southeast Turkey
Author keywords

[No Author keywords available]
Indexed keywords

TUBERCULOSTATIC AGENT; ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;
EID: 47549095066     PISSN: 00494755     EISSN: None     Source Type: Journal    
DOI: 10.1258/td.2007.070131     Document Type: Article
Times cited : (27)
References (10)
  • 1
    • 33746667801 scopus 로고    scopus 로고
    • Global incidence of multidrug-resistant tuberculosis
    • Zignol M, Hosseini MS, Wright A, et al., Global incidence of multidrug-resistant tuberculosis. J Infect Dis, 2006;194:479-85
    • (2006) J Infect Dis , vol.194 , pp. 479-485
    • Zignol, M.1    Hosseini, M.S.2    Wright, A.3
  • 2
    • 84872381586 scopus 로고    scopus 로고
    • Global Tuberculosis Control: Surveillance, Planning, Financing
    • WHO report 2006. Geneva: World Health Organization. (WHO/HTM/TB/2006.362)
    • WHO. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO report 2006. Geneva: World Health Organization. (WHO/HTM/TB/2006.362)
  • 3
    • 0034530775 scopus 로고    scopus 로고
    • Drug-resistant tuberculosis at the University Hospital in Gaziantep, South-eastern Turkey
    • Balci I, Dikensoy O, Bayram A, et al., Drug-resistant tuberculosis at the University Hospital in Gaziantep, South-eastern Turkey. J Int Med Res, 2000;28:300-6
    • (2000) J Int Med Res , vol.28 , pp. 300-306
    • Balci, I.1    Dikensoy, O.2    Bayram, A.3
  • 5
    • 3042613477 scopus 로고    scopus 로고
    • Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
    • Kart L, Altın R, Tor M, et al., Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis. Ann Clin Microbiol Antimicrob, 2002;16:1-6
    • (2002) Ann Clin Microbiol Antimicrob , vol.16 , pp. 1-6
    • Kart, L.1    Altın, R.2    Tor, M.3
  • 6
    • 32544433630 scopus 로고    scopus 로고
    • Risk factors for multidrug resistant tuberculosis in Europe: a systematic review
    • Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax, 2006;61:158-63
    • (2006) Thorax , vol.61 , pp. 158-163
    • Faustini, A.1    Hall, A.J.2    Perucci, C.A.3
  • 7
    • 0035460710 scopus 로고    scopus 로고
    • Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea
    • Lee JH, Chang JH. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med, 2001;16:173-9
    • (2001) Korean J Intern Med , vol.16 , pp. 173-179
    • Lee, J.H.1    Chang, J.H.2
  • 8
    • 15744362918 scopus 로고    scopus 로고
    • Epidemiological, clinical and biological profile of resistant or recurrent pulmonary tuberculosis in Abidjan
    • Kouassi B, Horo K, N'douba KA, et al., Epidemiological, clinical and biological profile of resistant or recurrent pulmonary tuberculosis in Abidjan. Bull Soc Pathol Exot, 2004;97:336-7
    • (2004) Bull Soc Pathol Exot , vol.97 , pp. 336-337
    • Kouassi, B.1    Horo, K.2    N'douba, K.A.3
  • 9
    • 24744441950 scopus 로고    scopus 로고
    • Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome
    • Surucuoglu S, Ozkutuk N, Celik P, et al., Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Ann Saudi Med, 2005;25:313-8
    • (2005) Ann Saudi Med , vol.25 , pp. 313-318
    • Surucuoglu, S.1    Ozkutuk, N.2    Celik, P.3
  • 10
    • 28844462512 scopus 로고    scopus 로고
    • Treatment results of multi drug resistant tuberculosis, a hospital based study
    • Yoshiyama T, Ogata H, Wada M. Treatment results of multi drug resistant tuberculosis, a hospital based study. Kekkaku, 2005;80:687-93
    • (2005) Kekkaku , vol.80 , pp. 687-693
    • Yoshiyama, T.1    Ogata, H.2    Wada, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.